Fulgent Genetics Inc (NAS:FLGT)
$ 22.07 -0.43 (-1.91%) Market Cap: 660.43 Mil Enterprise Value: 379.21 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 74/100

Q4 2023 Fulgent Genetics Inc Earnings Call Transcript

Feb 28, 2024 / 01:30PM GMT
Release Date Price: $23.41 (-8.14%)
Operator

Greetings and welcome to the Fulgent Genetics fourth quarter and full--year 2023 conference call and webcast.

At this time, all participants are in a listen--only mode. A question and answer session will follow the formal presentation. If anyone should require Operator assistance during the conference, please press star, zero on your telephone keypad. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Melanie Solomon, Investor Relations for Fulgent Genetics. Please go ahead.

Melanie Solomon
Fulgent Genetics Inc - Managing Director

Thank you. Good morning and welcome to the Fulgent fourth quarter and full year 2023 financial results conference call. On the call are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer.

The company's press release discussing the financial results is available on the Investor Relations section of the company's website,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot